We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BTCY market cap is 13.45M. The company's latest EPS is USD -0.5993 and P/E is -0.90.
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.42M | 3.39M | 7.65M | 9.64M | 12.06M |
| Operating Income | -10.93M | -13.35M | -18.02M | -15.41M | -8.83M |
| Net Income | -11.33M | -16.45M | -30.22M | -19.53M | -14.93M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2M | 4.44M | 16.68M | 6.51M | 5.94M |
| Total Liabilities | 5.01M | 11.27M | 18.82M | 26.36M | 35.92M |
| Total Equity | -3M | -6.83M | -2.15M | -19.85M | -31.47M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.86M | -11.08M | -15.16M | -13.55M | -6.69M |
| Investing | N/A | N/A | -30k | N/A | N/A |
| Financing | 8.88M | 12.2M | 25.17M | 2M | 6.74M |
| Market Cap | 13.45M |
| Price to Earnings Ratio | -0.90 |
| Price to Sales Ratio | 1.12 |
| Price to Cash Ratio | 17.09 |
| Price to Book Ratio | -0.45 |
| Dividend Yield | - |
| Shares Outstanding | 24.91M |
| Average Volume (1 week) | 21.1k |
| Average Volume (1 Month) | 51.03k |
| 52 Week Change | -84.92% |
| 52 Week High | 3.58 |
| 52 Week Low | 0.186 |
| Spread (Intraday) | 0.02 (3.64%) |
| Company Name | Biotricity Inc (QB) |
| Address |
701 s carson st carson city, nevada 89701 |
| Website | https://www.biotricity.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
